Probably the most ridiculous statement regarding C
Post# of 72440
(Total Views: 483)
Posted On: 09/21/2021 3:46:43 PM
Probably the most ridiculous statement regarding Clinical Trials success or failure...
"The CEO gets sued if trials fail"...
FIRST...NO NO BRILACIDIN TRIAL HAS EVER FAILED!..
SECONDLY... all PR's on BRILACIDIN are FACT BASED from INDEPENDENT RBL's, as well as the Peer-Reviewed articles those labs have presented,
THIRDLY...there would be NO CLINICAL TRIALS from any BP (or small) if the CEO could be sued because the outcome did not prove out...
SO empirical evidence is in great favor of a SUCCESSFUL CLINICAL TRIAL...
We need IPIX and BRILACIDIN desperately...
IMO all will be reported AFTER TOPLINE is reported...
IMO DeGrado's theory, the RBLs results, the RBL's reporting of continued Testing of Brilacidin...i.e. Science tells us...Leo is likely walking around with a smile on his face...
IMO...IGNORE GUESTIMATES TOPLINE HARD REPORTING DATES... presented here...we know we are likely "days" away...and
Know what you own and IMO time to put a smile on your face!
"The CEO gets sued if trials fail"...
FIRST...NO NO BRILACIDIN TRIAL HAS EVER FAILED!..
SECONDLY... all PR's on BRILACIDIN are FACT BASED from INDEPENDENT RBL's, as well as the Peer-Reviewed articles those labs have presented,
THIRDLY...there would be NO CLINICAL TRIALS from any BP (or small) if the CEO could be sued because the outcome did not prove out...
SO empirical evidence is in great favor of a SUCCESSFUL CLINICAL TRIAL...
We need IPIX and BRILACIDIN desperately...
IMO all will be reported AFTER TOPLINE is reported...
IMO DeGrado's theory, the RBLs results, the RBL's reporting of continued Testing of Brilacidin...i.e. Science tells us...Leo is likely walking around with a smile on his face...
IMO...IGNORE GUESTIMATES TOPLINE HARD REPORTING DATES... presented here...we know we are likely "days" away...and
Know what you own and IMO time to put a smile on your face!
(10)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼